Cargando…
Prevalence of treatment resistance and clozapine use in early intervention services
BACKGROUND: Treatment resistance causes significant burden in psychosis. Clozapine is the only evidence-based pharmacologic intervention available for people with treatment-resistant schizophrenia; current guidelines recommend commencement after two unsuccessful trials of standard antipsychotics. AI...
Autores principales: | Stokes, Imogen, Griffiths, Siân Lowri, Jones, Rowena, Everard, Linda, Jones, Peter B., Fowler, David, Hodgekins, Joanne, Amos, Tim, Freemantle, Nick, Sharma, Vimal, Marshall, Max, Singh, Swaran P., Birchwood, Max, Upthegrove, Rachel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576650/ https://www.ncbi.nlm.nih.gov/pubmed/32938513 http://dx.doi.org/10.1192/bjo.2020.89 |
Ejemplares similares
-
Structure and stability of symptoms in first episode psychosis: a longitudinal network approach
por: Griffiths, Siân Lowri, et al.
Publicado: (2021) -
Investigating trajectories of social recovery in individuals with first-episode psychosis: a latent class growth analysis
por: Hodgekins, Jo, et al.
Publicado: (2015) -
Five-year illness trajectories across racial groups in the UK following a first episode psychosis
por: Griffiths, Siân Lowri, et al.
Publicado: (2023) -
Social recovery therapy in combination with early intervention services for enhancement of social recovery in patients with first-episode psychosis (SUPEREDEN3): a single-blind, randomised controlled trial
por: Fowler, David, et al.
Publicado: (2018) -
A Synthetic Literature Review on the Management of Emerging Treatment Resistance in First Episode Psychosis: Can We Move towards Precision Intervention and Individualised Care?
por: Griffiths, Siân Lowri, et al.
Publicado: (2020)